AURKA and hepatocellular carcinoma: Summarizing the IHC staining results, the AURKA-specific antibody demonstrated moderate to strong staining in the nuclei and cytoplasm of HBV-HCC and Cr-HCC cases, whereas half of the control samples showed no staining and the remaining exhibited only weak cytoplasmic staining.